Overview
Triple agonist (GLP-1 + GIP + glucagon). Investigational compound under clinical trial; aggressive weight-loss and metabolic improvement signal beyond semaglutide or tirzepatide. Provided here as laboratory/research reference only — not yet FDA-approved.
Reported Dosing Ranges
Reference information only. Not medical advice, prescriptions, or recommendations.
Investigational Fat Loss (research only)
Dosage
0.25-1.0 mg
Frequency
3x weekly, titrate up as tolerated
Cycle Length
8-16 weeks
Timing
Any time of day; consistent weekly schedule ideal
Notes
Subcutaneous abdomen or thigh. Start at 0.25 mg 3x/week, titrate to 1.0 mg per dose. Unapproved investigational compound — currently in NCT trials.
Reconstitution Calculator
* U-30 recommended for this dose (5.0 units)
Your Dose
Draw to
5.0units
(0.050 mL) on a U-100 syringe
Syringe Fill
U-100 insulin syringe
Reconstitution
Concentration
5.00 mg/mL
mcg per mL
5000 mcg
Per Unit (IU)
50.0 mcg
Doses Per Vial
20 doses
Storage
🌡️ Refrigerate at 2-8°C
📋 Use within 30 days reconstituted.
⏱️ Shelf life: 30 days after reconstitution